网站主页 >> CAS数据库列表 >> 4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑
4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑
|
|
- CAS号:
- 215303-72-3
- 英文名:
- 4-[4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol
- 英文别名:
- CS-1470;RWJ 67657;JNJ 3026582;RWJ-67657;JNJ-3026582;RWJ-67657; RWJ-67657; RWJ-67657;4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-pyridin-4-ylimidazol-2-yl]but-3-yn-1-ol;4-(4-Fluorophenyl)-2-(4-hydroxy-1-butynyl)-1-(3-phenylpropyl)-5-(4-Pyridyl)iMidazole;4-[4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol;4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)but-3-yn-1-ol;3-Butyn-1-ol, 4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-
- 中文名:
- 4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑
- 中文别名:
- RWJ 67657,P38Α和P38Β抑制剂;4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑
- CBNumber:
- CB52518847
- 分子式:
- C27H24FN3O
- 分子量:
- 425.5
- MOL File:
- 215303-72-3.mol
|
|
|
4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑化学性质
-
熔点:
-
124℃
-
|
-
沸点:
-
611.8±65.0 °C(Predicted)
-
|
-
密度:
-
1.14±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at RT
-
|
-
溶解度:
-
≤10mg/ml in ethanol;5mg/ml in DMSO;2mg/ml in dimethyl formamide
-
|
-
酸度系数(pKa):
-
14.37±0.10(Predicted)
-
|
-
形态:
-
Yellow powder.
-
|
4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑性质、用途与生产工艺
RWJ-67657 (JNJ 3026582) 是一种具有口服活性的选择性 p38α 和 p38β 抑制剂,IC50 分别为 1 和 11 μM。RWJ-67657 对 p38γ 和 p38δ 无活性,是心脏保护剂,具有抗炎和抗肿瘤活性。
p38α
1 μM (IC
50
)
|
p38β
11 μM (IC
50
)
|
RWJ-67657 inhibits the release of TNF-α by lipopolysaccharide (LPS)-treated human peripheral blood mononuclear cells with an IC
50
of 3 nM, as well as the release of TNF-α from peripheral blood mononuclear cells treated with the superantigen staphylococcal enterotoxin B, with an IC
50
value of 13 nM.
RWJ67657 (10 μM; 24 hours) decreases colony formation in MCF-7 cells.
Cell Proliferation Assay
Cell Line:
|
MCF-7 breast carcinoma cells
|
Concentration:
|
10 μM
|
Incubation Time:
|
24 hours
|
Result:
|
Decreased colony formation.
|
RWJ-67657 inhibits TNF-alpha production in lipopolysaccharide-injected mice (87% inhibition at 50 mg/kg) and in rats (91% inhibition at 25 mg/kg) after oral administration.
RWJ-67657 (50 mg/kg; administered orally; once per day for 7 consecutive days) displays a potent anti-inflammatory effect. By both improving the functioning of endothelial progenitor cells (EPCs) and reducing inflammation, EPC transplantation plus RWJ-67657 administration synergistically promotes angiogenesis and neurogenesis after diabetic stroke.
Animal Model:
|
The
db/db
mice (male, 8 weeks old) with EPCs
|
Dosage:
|
50 mg/kg
|
Administration:
|
Administered orally; once per day for 7 consecutive days
|
Result:
|
Increased angiogenesis and neurogenesis of diabetic mice after cotreatment with EPCs transplantation.
|
4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-15505 | 4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑 RWJ-67657 | 215303-72-3 | 5mg | 800元 |
2024/04/30 | HY-15505 | 4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑 RWJ-67657 | 215303-72-3 | 10mM * 1mLin DMSO | 880元 |
4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑
生产厂家
215303-72-3, 4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑 相关搜索:
- 酶
- RWJ 67657,P38Α和P38Β抑制剂
- 4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑
- 215303-72-3
- RWJ-67657,p38 MAPK,Inhibitor,JNJ3026582,anti-tumor,RWJ 67657,p38α,JNJ-3026582,protective. Anti-inflammatory,MCF-7,inhibit,inflammation,RWJ67657,cardio,p38β
- 4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-pyridin-4-ylimidazol-2-yl]but-3-yn-1-ol
- 4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)but-3-yn-1-ol
- 4-[4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol ISO 9001:2015 REACH
- 3-Butyn-1-ol, 4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-
- RWJ-67657; RWJ-67657; RWJ-67657
- CS-1470
- RWJ-67657;JNJ-3026582
- JNJ 3026582
- 4-(4-Fluorophenyl)-2-(4-hydroxy-1-butynyl)-1-(3-phenylpropyl)-5-(4-Pyridyl)iMidazole
- RWJ 67657
- 4-[4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol